HR 203 — A Resolution directing the Joint State Government Commission to conduct a study of reported patient safety events and issue a report with recommendations for reducing reportable patient safety events and improving patient safety.
Congress · introduced 2025-04-22
Latest action: — (Remarks see House Journal Page ), May 5, 2026
Sponsors
- Manuel Guzman (D, PA-127) — sponsor · 2025-04-22
- Carol Hill-Evans (D, PA-95) — cosponsor · 2025-04-22
- Benjamin V. Sanchez (D, PA-153) — cosponsor · 2025-04-22
- Nikki Rivera (D, PA-96) — cosponsor · 2025-04-22
- Johanny Cepeda-Freytiz (D, PA-129) — cosponsor · 2025-04-22
- Robert F. Matzie (D, PA-16) — cosponsor · 2025-04-22
- Tarik Khan (D, PA-194) — cosponsor · 2025-04-22
Action timeline
- · house — Referred to HEALTH, April 22, 2025
- · house — Reported as amended, Feb. 3, 2026
- · house — Amended, May 5, 2026
- · house — Adopted, May 5, 2026 (126-75)
- · house — (Remarks see House Journal Page ), May 5, 2026
Text versions
No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.
Bill text
Printer's No. 1458 · 7,223 characters · source document
Read the full text
PRINTER'S NO. 1458
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No. 203
Session of
2025
INTRODUCED BY GUZMAN, HILL-EVANS, SANCHEZ, RIVERA AND CEPEDA-
FREYTIZ, APRIL 22, 2025
REFERRED TO COMMITTEE ON HEALTH, APRIL 22, 2025
A RESOLUTION
1 Directing the Joint State Government Commission to conduct a
2 study of medication errors and issue a report to provide
3 recommendations on reduction of errors and improved patient
4 safety.
5 WHEREAS, According to the National Coordinating Council for
6 Medication Error Reporting and Prevention, medication errors are
7 preventable mistakes made while prescribing or issuing
8 medication to a patient; and
9 WHEREAS, Medication errors can happen at any step in the
10 process of prescribing medication, including when the medicine
11 is prescribed, when the prescribed medication is entered into
12 the computer system, when the medication is dispensed or when
13 the medication is taken by an individual; and
14 WHEREAS, Medication errors may have serious consequences such
15 as death, hospitalization, disability or birth defects; and
16 WHEREAS, Didier Epopa, a patient at Mercy Fitzgerald Hospital
17 in Darby, Delaware County, was issued the wrong medication,
18 which caused his body to seize and muscles to tighten; and
19 WHEREAS, The error occurred because a pharmacy technician at
1 Mercy Fitzgerald Hospital wrongly labeled the intravenous bag
2 containing the medicine; and
3 WHEREAS, A report on the medication error incident later
4 found that the pharmacy technician was in fact not a technician,
5 but rather a certified intern and should have been supervised;
6 and
7 WHEREAS, Under current State law, pharmacists are not
8 required to notify the Pennsylvania Board of Pharmacy about
9 medication errors, but instead must notify the prescribing
10 doctor of a medication error within 24 hours of the error; and
11 WHEREAS, Since pharmacists are not required to notify a State
12 agency, many times this leads the hospital to only conduct an
13 internal investigation of the error rather than involving the
14 Department of Health; and
15 WHEREAS, Hospitals are required to report "serious events,"
16 which are instances that result in death or serious harm to a
17 patient, and "incidents," which are events that could have
18 resulted in the death or serious harm to a patient, to the
19 Pennsylvania Patient Safety Reporting System; and
20 WHEREAS, According to the Pennsylvania Patient Safety
21 Authority's 2022 Annual Report, there were 257,000 reports made,
22 which included 247,000 reports regarding "incidents" and 10,000
23 reports regarding "serious events"; and
24 WHEREAS, The United States Food and Drug Administration (FDA)
25 has worked to reduce medication errors by reviewing medication
26 names, packaging, labeling and directions for all medications
27 and required barcodes to appear on some medications for the
28 purpose of ensuring the correct strength and type of medication;
29 and
30 WHEREAS, The FDA also released a guidance in 2016 titled
20250HR0203PN1458 - 2 -
1 "Safety Considerations for Product Design to Minimize Medication
2 Errors" to help reduce medication errors; and
3 WHEREAS, Medication errors could be further reduced with the
4 institution of adequate staff-to-patient ratios, so nurses and
5 other health care professionals are not overwhelmed with a large
6 number of patients and can provide better quality of care to
7 patients; and
8 WHEREAS, All Pennsylvanians would benefit from reduced
9 occurrences of medication errors and improved patient safety;
10 and
11 WHEREAS, The House of Representatives should craft policy
12 informed by a thorough understanding of how to reduce medication
13 errors and improve patient safety; therefore be it
14 RESOLVED, That the House of Representatives direct the Joint
15 State Government Commission to conduct a study of medication
16 errors and issue a report to provide recommendations on
17 reduction of errors and improved patient safety; and be it
18 further
19 RESOLVED, That the study include how medication errors occur
20 in different settings where patients are prescribed and
21 administered medication, including acute care hospitals,
22 rehabilitation centers, senior living centers, long-term care
23 facilities and pharmacies; and be it further
24 RESOLVED, That the Joint State Government Commission appoint
25 an advisory committee to assist in this study; and be it further
26 RESOLVED, That the advisory committee be composed of the
27 following members:
28 (1) The Secretary of Health or a designee.
29 (2) One individual representing The Hospital and
30 Healthsystem Association of Pennsylvania.
20250HR0203PN1458 - 3 -
1 (3) One individual representing the Pennsylvania Medical
2 Society.
3 (4) One individual representing the Pennsylvania
4 Pharmacists Association.
5 (5) One individual representing Pennsylvania State
6 Nurses Association.
7 (6) One individual from the Pennsylvania Patient
8 Advocacy Program within the Department of Health.
9 (7) One licensed pharmacist to be selected by the Joint
10 State Government Commission.
11 (8) One licensed registered nurse to be selected by the
12 Joint State Government Commission.
13 (9) One licensed physician to be selected by the Joint
14 State Government Commission.
15 (10) Any other member identified as being helpful by the
16 Joint State Government Commission;
17 and be it further
18 RESOLVED, That the study include policies adopted by other
19 states to reduce medication errors; and be it further
20 RESOLVED, That the study include best practices supported by
21 stakeholders such as The Hospital and Healthsystem Association
22 of Pennsylvania, the Pennsylvania Medical Society, the
23 Pennsylvania Pharmacists Association and the Pennsylvania State
24 Nurses Association; and be it further
25 RESOLVED, That the study include a review of current
26 Pennsylvania statute and regulations related to administration
27 of medicine and reporting of medication errors; and be it
28 further
29 RESOLVED, That the study include a review of the agency in
30 the Commonwealth with regulatory oversight of medication errors;
20250HR0203PN1458 - 4 -
1 and be it further
2 RESOLVED, That the Joint State Government Commission present
3 its report to the House of Representatives no later than 18
4 months after the adoption of this resolution.
20250HR0203PN1458 - 5 -Connected on the graph
Outbound (1)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| — | referred_to_committee | Pennsylvania House Health Committee | — | pa-leg |
The full graph
Every typed relationship touching this entity — 1 edge across 1 category. Grouped by what the connection is; the heaviest few are shown, with a link to the full list.
Committees
→ Referred to committee 1 edge
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Manuel Guzman (D, state_lower PA-127) | sponsor | 0 | — | 5 |
| 2 | Benjamin V. Sanchez (D, state_lower PA-153) | cosponsor | 0 | — | 1 |
| 3 | Carol Hill-Evans (D, state_lower PA-95) | cosponsor | 0 | — | 1 |
| 4 | Johanny Cepeda-Freytiz (D, state_lower PA-129) | cosponsor | 0 | — | 1 |
| 5 | Nikki Rivera (D, state_lower PA-96) | cosponsor | 0 | — | 1 |
| 6 | Robert F. Matzie (D, state_lower PA-16) | cosponsor | 0 | — | 1 |
| 7 | Tarik Khan (D, state_lower PA-194) | cosponsor | 0 | — | 1 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)
By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-20 · was referred to Pennsylvania House Health Committee · pa-leg